If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

Share Price is delayed by 15 minutes
Get Live Data
1.00    -0.10 (-9.09%)
Bid:
1.05
Ask:
1.08
Spread: 0.03 (2.857%)
Market Cap: $717.95m
EFGD Live PriceLast checked at - London Stock Exchange

Intraday Efg-hold.gdr S Share Chart

  • This share is an international stock.

Third Quarter 2016 Results

15 Nov 2016 07:28

RNS Number : 1851P
EFG-Hermes Holdings SAE
15 November 2016
 

EFG HERMES REPORTS THIRD QUARTER 2016GROUP EARNINGS FROM CONTINUED OPERATIONS OF EGP41 MILLION; ON OPERATING REVENUE OF EGP294 MILLION

Cairo, November 15th, 2016 - EFG Hermes reported today net profit after tax and minority interest from continued operations of EGP41 million in 3Q16, up 3% Y-o-Y. Operating revenue rose 28% Y-o-Y to EGP294 million in 3Q16. Net profit after tax and minority interest from continued and discontinued operations reached EGP151 million, up 25% Y-o-Y in 3Q16. The Group total assets stood at EGP14.0 billion at the end of 3Q16.http://www.rns-pdf.londonstockexchange.com/rns/1851P_-2016-11-15.pdf

http://www.rns-pdf.londonstockexchange.com/rns/1851P_1-2016-11-15.pdf

Key Highlights

3Q2016

 

· EFG Hermes reported buoyant results in 3Q16 despite a seasonally weak quarter; with the burgeoning non-bank finance platform supporting the overall performance. The Firm reported a net profit after tax and minority interest from continued operations of EGP41 million, up 3% Y-o-Y in 3Q16;

· On the operational level, the Firm recorded a net operating profit of EGP76 million, up 7% Y-o-Y; as higher revenues overshadowed higher expenses;

· Total operating revenues increased 28% Y-o-Y to EGP294 million in 3Q16; predominantly on strong revenue generated from the growing non-bank finance platform, higher contribution from one of our core segments, namely Brokerage, and capital gain realized from seed capital redemption;

· Total operating expenses rose 37% Y-o-Y to EGP219 million in 3Q16; mainly on additional costs associated with the new businesses, Leasing and Tanmeyah. However, employee expenses/ operating revenue came at 47% in 3Q16; an accomplishment given the rising inflationary pressures, and the EGP devaluation in 1Q16 which impacts our overseas salaries;

· During the period, EFG Hermes reported a net profit after tax and minority interest from continued and discontinued operations of EGP151 million, up 25% Y-o-Y in 3Q16; reflecting the adjustment of impairment charges booked in 1Q16 and associated with the sale of Credit Libanais. This comes in accordance with the Egyptian Accounting Standards, which necessitates an adjustment in the occurrence of a subsequent material event - the EGP devaluation;

· We continue to divest our remaining stake in Credit Libanais post the sale of our majority stake in the Bank and its subsequent deconsolidation in 2Q16. In 3Q16, we offloaded an additional 3.3% of the Bank's shares, thus leaving the Firm with 16.1% stake at the end of the period.

 

 

For full report and financial statements, please click on the links on top of the page.

 

 

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Head of Investor Relations

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

Fax: +20(0)2 3535 7017

www.efg-hermes.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTDELBFQFFLFBX
Date   Source Headline
16th Dec 20147:41 amRNSPrivate Equity closes transaction
8th Dec 20147:00 amRNSSale of half a floor of the Index Tower
11th Nov 20147:38 amRNS3rd Quarter Results
5th Nov 20147:00 amRNSNotice of Results - 3Q2014
30th Oct 20141:01 pmRNSAnnouncement re: Appointment of Vice Chairman
2nd Oct 20148:17 amRNSBoard of Directors Resolutions
1st Oct 20148:53 amRNSPrivate Equity EDPR France Transaction
14th Aug 20147:34 amRNS2Q2014 Results
24th Jul 20149:25 amRNSBoard Directors Resolutions
18th Jul 20143:48 pmRNSSecond Price Monitoring Extn
18th Jul 20143:42 pmRNSPrice Monitoring Extension
30th Jun 20147:00 amRNSBOD Statement on IFA Report
27th Jun 20147:00 amRNSBoard of Directors Resolutions
25th Jun 20148:58 amRNSExpected Admission of Additional Listing
24th Jun 20147:58 amRNSPublication of Prospectus
18th Jun 201410:52 amRNSAppointing an IFA to opine on the tender offer
10th Jun 20148:13 amRNSBoD statement
9th Jun 20148:45 amRNSStatement re EFSA Statement on Tender Offer
19th May 20149:24 amRNSStatement re Sarwa Capital Strategic Alliance
19th May 20147:00 amRNSAGM Statement (Summary of Resolutions)
15th May 20149:30 amRNS1st Quarter Results
8th May 20141:49 pmRNSDisposal
7th May 20141:52 pmRNSDisposal
30th Apr 20148:59 amRNSNotice of AGM
27th Mar 20147:57 amRNSFY2013 Results
5th Mar 20142:31 pmRNSStatement
3rd Feb 20147:00 amRNSBoD Resolutions
16th Jan 20141:21 pmRNSBuyback Details
9th Jan 20147:00 amRNSTreasury Stock
9th Jan 20147:00 amRNSBoD Resolutions
6th Jan 20147:23 amRNSSale of Real Estate Unit
2nd Jan 20147:30 amRNSAppointment of New CFO
17th Dec 20137:28 amRNSKarim Awad appointed as Group Co-CEO
14th Nov 20138:12 amRNS3rd Quarter Results
13th Nov 20138:55 amRNSStatement Executive Committee Reformulation
21st Oct 20133:45 pmRNSSecond Price Monitoring Extn
21st Oct 20133:40 pmRNSPrice Monitoring Extension
8th Oct 20137:00 amRNSCo-CEO of EFG Hermes Holding Steps Down
1st Oct 20138:52 amRNSStatement Appointment of Asset Management Head
30th Sep 20133:45 pmRNSSecond Price Monitoring Extn
30th Sep 20133:40 pmRNSPrice Monitoring Extension
12th Sep 20139:08 amRNSBonus Share Distribution
2nd Sep 20137:00 amRNS2nd Quarter Results
30th Jul 20139:17 amRNSStatement re Sale of Non-core Assets
25th Jul 201310:06 amRNSResult of second EGM
8th Jul 20139:18 amRNSNotice of EGM
8th Jul 20137:00 amRNSResult of AGM and EGM
17th Jun 20139:11 amRNSNotice of EGM
17th Jun 20139:08 amRNSNotice of AGM
4th Jun 20139:34 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.